OXFORD BIOSCIENCE PARTNERS IV LP Insider Trading Transactions
FREE EMAIL WATCHDOG
Get free email notifications about insider trading for OXFORD BIOSCIENCE PARTNERS IV LP.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insider Transactions | Monthly Overview
Get the latest insider transactions of OXFORD BIOSCIENCE PARTNERS IV LP. OXFORD BIOSCIENCE PARTNERS IV LP is in Solexa, Inc. ($LYNX) and 10% Owner in Solexa, Inc. ($LYNX) and 10% Owner in SIRNA THERAPEUTICS INC ($RNAI) and 10% Owner in ACADIA PHARMACEUTICALS INC ($ACAD) and 10% Owner in Cyberkinetics Neurotechnology Systems, Inc. ($CYKN) and 10% Owner in Trubion Pharmaceuticals, Inc ($TRBN).
Latest Insider Trading Transactions of OXFORD BIOSCIENCE PARTNERS IV LP
1 Week | 2 Weeks | 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | |
---|---|---|---|---|---|---|---|
No. of Purchases | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Value of Purchases ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
No. of Sales | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Value of Sales ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Sentiment: All, ACAD, CYKN, RNAI, LYNX, TRBN
Page: 1
Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
---|---|---|---|---|---|---|---|---|---|---|---|
Oct 25 2006 | TRBN | Trubion Pharmaceut ... | OXFORD BIOSCIENCE PARTNERS IV ... | 10% Owner | Option Exercise | C | 0.00 | 11,577 | 0 | 0 | |
Oct 25 2006 | TRBN | Trubion Pharmaceut ... | OXFORD BIOSCIENCE PARTNERS IV ... | 10% Owner | Option Exercise | C | 0.00 | 9,800 | 0 | 0 | |
Oct 25 2006 | TRBN | Trubion Pharmaceut ... | OXFORD BIOSCIENCE PARTNERS IV ... | 10% Owner | Option Exercise | C | 0.00 | 1,157,717 | 0 | 0 | |
Oct 25 2006 | TRBN | Trubion Pharmaceut ... | OXFORD BIOSCIENCE PARTNERS IV ... | 10% Owner | Option Exercise | C | 0.00 | 976,592 | 0 | 0 | |
Oct 25 2006 | TRBN | Trubion Pharmaceut ... | OXFORD BIOSCIENCE PARTNERS IV ... | 10% Owner | Buy | C | 0.00 | 21,377 | 0 | 21,790 | 413 to 21.8 K (+5,176.03 %) |
Oct 25 2006 | TRBN | Trubion Pharmaceut ... | OXFORD BIOSCIENCE PARTNERS IV ... | 10% Owner | Buy | C | 0.00 | 2,134,309 | 0 | 2,175,510 | 41.2 K to 2.2 M (+5,180.24 %) |
Oct 19 2006 | TRBN | Trubion Pharmaceut ... | OXFORD BIOSCIENCE PARTNERS IV ... | 10% Owner | Buy | P | 13.00 | 413 | 5,369 | 413 | 0 to 413 |
Oct 19 2006 | TRBN | Trubion Pharmaceut ... | OXFORD BIOSCIENCE PARTNERS IV ... | 10% Owner | Buy | P | 13.00 | 41,201 | 535,613 | 41,201 | 0 to 41.2 K |
Oct 20 2006 | CYKN | Cyberkinetics Neur ... | OXFORD BIOSCIENCE PARTNERS IV ... | 10% Owner | Option Exercise | P | 1.40 | 4,139 | 5,795 | 4,139 | |
Oct 20 2006 | CYKN | Cyberkinetics Neur ... | OXFORD BIOSCIENCE PARTNERS IV ... | 10% Owner | Option Exercise | P | 1.40 | 412,528 | 577,539 | 412,528 | |
Oct 20 2006 | CYKN | Cyberkinetics Neur ... | OXFORD BIOSCIENCE PARTNERS IV ... | 10% Owner | Buy | P | 1.20 | 8,278 | 9,934 | 104,707 | 96.4 K to 104.7 K (+8.58 %) |
Oct 20 2006 | CYKN | Cyberkinetics Neur ... | OXFORD BIOSCIENCE PARTNERS IV ... | 10% Owner | Buy | P | 1.20 | 825,056 | 990,067 | 10,436,017 | 9.6 M to 10.4 M (+8.58 %) |
Jan 20 2006 | LYNX | Solexa, Inc. | OXFORD BIOSCIENCE PARTNERS IV ... | Sell | J | 0.00 | 19,867 | 0 | 10,388 | 30.3 K to 10.4 K (-65.67 %) | |
Jan 20 2006 | LYNX | Solexa, Inc. | OXFORD BIOSCIENCE PARTNERS IV ... | Sell | J | 0.00 | 1,980,133 | 0 | 1,035,355 | 3 M to 1 M (-65.67 %) | |
Jul 14 2005 | LYNX | Solexa, Inc. | OXFORD BIOSCIENCE PARTNERS IV ... | 10% Owner | Option Exercise | P | 5.00 | 2,732 | 13,660 | 2,732 | |
Jul 14 2005 | LYNX | Solexa, Inc. | OXFORD BIOSCIENCE PARTNERS IV ... | 10% Owner | Option Exercise | P | 5.00 | 272,268 | 1,361,340 | 272,268 | |
Jul 14 2005 | LYNX | Solexa, Inc. | OXFORD BIOSCIENCE PARTNERS IV ... | 10% Owner | Grant | A | 0.00 | 20 | 0 | 30,255 | 30.2 K to 30.3 K (+0.07 %) |
Jul 14 2005 | LYNX | Solexa, Inc. | OXFORD BIOSCIENCE PARTNERS IV ... | 10% Owner | Buy | P | 4.00 | 5,464 | 21,856 | 30,235 | 24.8 K to 30.2 K (+22.06 %) |
Jul 14 2005 | LYNX | Solexa, Inc. | OXFORD BIOSCIENCE PARTNERS IV ... | 10% Owner | Grant | A | 0.00 | 1,986 | 0 | 3,015,508 | 3 M to 3 M (+0.07 %) |
Jul 14 2005 | LYNX | Solexa, Inc. | OXFORD BIOSCIENCE PARTNERS IV ... | 10% Owner | Buy | P | 4.00 | 544,536 | 2,178,144 | 3,013,522 | 2.5 M to 3 M (+22.06 %) |
Jul 08 2005 | RNAI | SIRNA THERAPEUTICS ... | OXFORD BIOSCIENCE PARTNERS IV ... | 10% Owner | Option Exercise | P | 1.92 | 4,470 | 8,582 | 4,470 | |
Jul 08 2005 | RNAI | SIRNA THERAPEUTICS ... | OXFORD BIOSCIENCE PARTNERS IV ... | 10% Owner | Option Exercise | P | 1.92 | 445,529 | 855,416 | 445,529 | |
Jul 08 2005 | RNAI | SIRNA THERAPEUTICS ... | OXFORD BIOSCIENCE PARTNERS IV ... | 10% Owner | Buy | P | 1.60 | 12,418 | 19,869 | 58,267 | 45.8 K to 58.3 K (+27.08 %) |
Jul 08 2005 | RNAI | SIRNA THERAPEUTICS ... | OXFORD BIOSCIENCE PARTNERS IV ... | 10% Owner | Buy | P | 1.60 | 1,237,582 | 1,980,131 | 5,807,127 | 4.6 M to 5.8 M (+27.08 %) |
Sep 28 2005 | CYKN | Cyberkinetics Neur ... | OXFORD BIOSCIENCE PARTNERS IV ... | 10% Owner | Option Exercise | P | 1.60 | 12,417 | 19,867 | 12,417 | |
Sep 28 2005 | CYKN | Cyberkinetics Neur ... | OXFORD BIOSCIENCE PARTNERS IV ... | 10% Owner | Option Exercise | P | 1.60 | 1,237,583 | 1,980,133 | 1,237,583 | |
Sep 28 2005 | CYKN | Cyberkinetics Neur ... | OXFORD BIOSCIENCE PARTNERS IV ... | 10% Owner | Buy | P | 1.20 | 24,834 | 29,801 | 96,429 | 71.6 K to 96.4 K (+34.69 %) |
Sep 28 2005 | CYKN | Cyberkinetics Neur ... | OXFORD BIOSCIENCE PARTNERS IV ... | 10% Owner | Buy | P | 1.20 | 2,475,166 | 2,970,199 | 9,610,961 | 7.1 M to 9.6 M (+34.69 %) |
Aug 02 2005 | ACAD | ACADIA PHARMACEUTI ... | OXFORD BIOSCIENCE PARTNERS IV ... | 10% Owner | Option Exercise | P | 8.15 | 89,900 | 732,505 | 236,500 | |
Apr 21 2005 | ACAD | ACADIA PHARMACEUTI ... | OXFORD BIOSCIENCE PARTNERS IV ... | 10% Owner | Option Exercise | P | 8.15 | 146,600 | 1,194,497 | 146,600 | |
Apr 21 2005 | ACAD | ACADIA PHARMACEUTI ... | OXFORD BIOSCIENCE PARTNERS IV ... | 10% Owner | Buy | P | 6.82 | 586,402 | 4,000,024 | 3,160,238 | 2.6 M to 3.2 M (+22.78 %) |
Jan 04 2005 | RNAI | SIRNA THERAPEUTICS ... | OXFORD BIOSCIENCE PARTNERS IV ... | 10% Owner | Option Exercise | X | 2.52 | 8,130 | 20,488 | 8,943 | |
Jan 04 2005 | RNAI | SIRNA THERAPEUTICS ... | OXFORD BIOSCIENCE PARTNERS IV ... | 10% Owner | Option Exercise | P | 3.85 | 8,943 | 34,431 | 17,073 | |
Jan 04 2005 | RNAI | SIRNA THERAPEUTICS ... | OXFORD BIOSCIENCE PARTNERS IV ... | 10% Owner | Option Exercise | P | 2.52 | 8,130 | 20,488 | 8,130 | |
Jan 04 2005 | RNAI | SIRNA THERAPEUTICS ... | OXFORD BIOSCIENCE PARTNERS IV ... | 10% Owner | Option Exercise | H | 2.52 | 8,130 | 20,488 | 0 | |
Jan 04 2005 | RNAI | SIRNA THERAPEUTICS ... | OXFORD BIOSCIENCE PARTNERS IV ... | 10% Owner | Option Exercise | X | 2.52 | 810,315 | 2,041,994 | 891,346 | |
Jan 04 2005 | RNAI | SIRNA THERAPEUTICS ... | OXFORD BIOSCIENCE PARTNERS IV ... | 10% Owner | Option Exercise | P | 3.85 | 891,346 | 3,431,682 | 1,701,661 | |
Jan 04 2005 | RNAI | SIRNA THERAPEUTICS ... | OXFORD BIOSCIENCE PARTNERS IV ... | 10% Owner | Option Exercise | P | 2.52 | 810,315 | 2,041,994 | 810,315 | |
Jan 04 2005 | RNAI | SIRNA THERAPEUTICS ... | OXFORD BIOSCIENCE PARTNERS IV ... | 10% Owner | Option Exercise | H | 2.52 | 810,315 | 2,041,994 | 0 | |
Jan 04 2005 | RNAI | SIRNA THERAPEUTICS ... | OXFORD BIOSCIENCE PARTNERS IV ... | 10% Owner | Buy | X | 2.52 | 8,130 | 20,488 | 45,849 | 37.7 K to 45.8 K (+21.55 %) |
Jan 04 2005 | RNAI | SIRNA THERAPEUTICS ... | OXFORD BIOSCIENCE PARTNERS IV ... | 10% Owner | Buy | X | 2.52 | 810,315 | 2,041,994 | 4,569,545 | 3.8 M to 4.6 M (+21.56 %) |
Page: 1